| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |